Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Immunopharma AS

Closing information (x1000 NOK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 482,039 Less Arrow 390,769 Less Arrow 316,584
Financial expenses 9,723 More Arrow 9,970 More Arrow 11,777
Earnings before taxes -49,721 More Arrow -23,267 More Arrow -19,566
Total assets 381,162 Less Arrow 351,239 More Arrow 391,175
Current assets 229,912 Less Arrow 131,972 Less Arrow 104,002
Current liabilities 106,889 Less Arrow 74,463 Less Arrow 71,964
Equity capital 204,442 More Arrow 243,941 Less Arrow 138,023
- share capital 13,865 Less Arrow 13,378 Less Arrow 10,415
Employees (average) 8 Less Arrow 1

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 53.6% More Arrow 69.5% Less Arrow 35.3%
Turnover per employee 48,846 More Arrow 316,584
Profit as a percentage of turnover -10.3% More Arrow -6.0% Less Arrow -6.2%
Return on assets (ROA) -10.5% More Arrow -3.8% More Arrow -2.0%
Current ratio 215.1% Less Arrow 177.2% Less Arrow 144.5%
Return on equity (ROE) -24.3% More Arrow -9.5% Less Arrow -14.2%
Change turnover 91,270 Less Arrow 74,185 More Arrow 314,247
Change turnover % 23% Equal arrow 23% More Arrow 13447%
Chg. No. of employees 7 Less Arrow 0
Chg. No. of employees % 700% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.